Serotonin and migraine: Biology and clinical implications

Cephalalgia

Volumn 27, Issue 11, 2007, Pages 1293-1300

  Hamel, E ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT synthesis; 5 HT1 receptor agonists; Migraine headache; Raphe nucleus; Serotonergic neurotransmission; Serotonin transporter; Tryptophan hydroxylase

Indexed keywords

SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ABSENTEEISM; BIOLOGY; BRAIN STEM; CLINICAL FEATURE; HEADACHE; HUMAN; MIGRAINE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; QUALITY OF LIFE; RAPHE NUCLEUS; SEROTONIN METABOLISM; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SHORT SURVEY; SYMPTOM; ANIMAL; BRAIN; GENETICS; METABOLISM; REVIEW;

ANIMALS; BRAIN; HUMANS; MIGRAINE DISORDERS; SEROTONIN;

EID: 35448942208     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01476.x     Document Type: Short Survey

References (65)

1. Lance JW. Current concepts of migraine pathogenesis. Neurology 1993 43 (Suppl. 3 S11 15.
2. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003 299:76.
3. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992 72:165 229.
4. Hornung JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003 26:331 43.
5. Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res 2006 1085:11 18.
6. Johnson MP, Griffiths LR. A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach. J Hum Genet 2005 50:607 10.
7. Erdal N, Herken H, Yilmaz M, Erdal E, Bayazit YA. The A218C polymorphism of tryptophan hydroxylase gene and migraine. J Clin Neurosci 2007 14:249 51.
8. Marziniak M, Mossner R, Benninghoff J, Syagailo YV, Lesch KP, Sommer C. Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine. J Neural Transm 2004 111:603 9.
9. Filic V, Vladic A, Stefulj J, Cicin-Sain L, Balija M, Sucic Z, Jernej B. Monoamine oxidases A and B gene polymorphisms in migraine patients. J Neurol Sci 2005 228:149 53.
10. Yang XS, Xu XP, Yang QD. No association of C-1019G promoter polymorphism of 5-HT1A receptor gene with migraine. Eur J Neurol 2006 13:533 5.
11. Nyholt DR, Curtain RP, Gaffney PT, Brimage P, Goadsby PJ, Griffiths LR. Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor gene. Cephalalgia 1996 16:463 7.
12. Erdal ME, Herken H, Yilmaz M, Bayazit YA. Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci 2001 188:99 101.
13. Juhasz G, Zsombok T, Laszik A, Gonda X, Sotonyi P, Faludi G, Bagdy G. Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 2003 17:231 40.
14. Burnet PW, Harrison PJ, Goodwin GM, Battersby S, Ogilvie AD, Olesen J, Russell MB. Allelic variation in the serotonin 5-HT2C receptor gene and migraine. Neuroreport 1997 8:2651 3.
15. Johnson MP, Lea RA, Curtain RP, MacMillan JC, Griffiths LR. An investigation of the 5-HT2C receptor gene as a migraine candidate gene. Am J Med Genet B Neuropsychiatr Genet 2003 117:86 9.
16. Maassen Van Den Brink A, Vergouwe MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR. 5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache 1998 38:288 91.
17. Maassen Van Den Brink A, Vergouwe MN, Ophoff RA, Naylor SL, Dauwerse HG, Saxena PR et al. Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. Am J Med Genet 1998 77:415 20.
18. Todt U, Freudenberg J, Goebel I, Heinze A, Heinze-Kuhn K, Rietschel M et al. Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura. Neurology 2006 67:1707 9.
19. Marziniak M, Mossner R, Schmitt A, Lesch KP, Sommer C. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 2005 64:157 9.
20. Borroni B, Brambilla C, Liberini P, Rao R, Archetti S, Gipponi S et al. Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J Headache Pain 2005 6:182 4.
21. Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 2002 42:893 5.
22. Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA. Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci 2001 186:27 30.
23. Park JW, Han SR, Yang DW, Kim YI, Lee KS. Serotonin transporter protein polymorphism and harm avoidance personality in migraine without aura. Headache 2006 46:991 6.
24. Sicuteri F, Testi A, Anselmi B. Biochemical investigations in headache: increase in hydroxytryindoleacetic acid excretion during migraine attacks. Int Arch Allergy Appl Immunol 1961 19:55 8.
25. Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993 13:151 65.
26. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989 39:1239 42.
27. Humphrey PPA. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 1991 238:S38 S44.
28. Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology 2005 65:620 2.
29. Drummond PD. Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia 2006 26:1225 33.
30. Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R et al. Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 2007 254:789 96.
31. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993 33:173 87.
32. Coppola G, Vandenheede M, Di Clemente L, Ambrosini A, Fumal A, De Pasqua V, Schoenen J. Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks. Brain 2005 128:98 103.
33. Proietti-Cecchini A, Schoenen JAJ. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia 1997 17:849 54.
34. Afra J, Proietti Cecchini A, Sandor PS, Schoenen J. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks. Clin Neurophysiol 2000 111:1124 9.
35. Judit A, Sandor PS, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia 2000 20:714 9.
36. Panconesi A, Sicuteri R. Headache induced by serotonergic agonists - a key to the interpretation of migraine pathogenesis? Cephalalgia 1997 17:3 14.
37. Bickel A, Kornhuber J, Maihofner C, Ropohl A. Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report. Pharmacopsychiatry 2005 38:327 8.
38. Fozard JR, Kalkman HO. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg's Arch Pharmacol 1994 350:225 9.
39. Kalkman HO. Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockage? Life Sci 1994 54:641 4.
40. Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H. Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci 1996 8:959 67.
41. Chugani DC, Niimura K, Chaturvedi S, Muzik O, Fakhouri M, Lee ML, Chugani HT. Increased brain serotonin synthesis in migraine. Neurology 1999 53:1473 9.
42. Ozkul Y, Bozlar S. Effects of fluoxetine on habituation of pattern reversal visually evoked potentials in migraine prophylaxis. Headache 2002 42:582 7.
43. Diener HC, Scholz E, Dichgans J, Gerber WD, Jack A, Bille A, Niederberger U. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 1989 25:125 30.
44. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995 1:658 60.
45. Diksic M, Sakai Y, Dobson C, Aubé M, Hamel E. Acute sumatriptan reduces head pain concurrently with brain serotonin synthesis during spontaneous migraine attacks as measured by positron emission tomography (PET). 8th European Headache Federation (EHF) Congress, Valencia April 26-29, 2006.
46. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002 8:136 42.
47. Hadjikhani N, Sanchez del Rio M, Wu O, Schwartz D, Bakker D, Fischi B et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001 98:4687 92.
48. Chédotal A, Hamel E. Serotonin-synthesizing nerve fibers in rat and cat cerebral arteries and arterioles: immunohistochemistry of tryptophan-5-hydroxylase. Neurosci Lett 1990 116:269 74.
49. Cohen Z, Bonvento G, Lacombe P, Hamel E. Serotonin in the regulation of brain microcirculation. Prog Neurobiol 1996 50:335 62.
50. Moreno MJ, Conde MV, de la Luz Fraile M, Fernandez LH, Lopez de Pablo AL, Marco EJ. Lesion of the dorsal raphe nucleus induces supersensitivity to serotonin in isolated cat middle cerebral artery. Brain Res 1991 538:324 8.
51. Supornsilpchai W, Sanguanrangsirikul S, Maneesri S, Srikiatkhachorn A. Serotonin depletion, cortical spreading depression, and trigeminal nociception. Headache 2006 46:34 9.
52. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich Cohort study of young adults. Arch Gen Psychiatry 1990 47:849 53.
53. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Tips 1994 15:220 6.
54. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 1990 47:411 8.
55. Pringsheim T, Diksic M, Dobson C, Nguyen K, Hamel E. Selective decrease in serotonin synthesis rate in rat brainstem raphe nuclei following chronic administration of low doses of amitriptyline: an effect compatible with an anti-migraine effect. Cephalalgia 2003 23:367 75.
56. Hamel E. The biology of serotonin receptors: focus on migraine and treatment. Can J Neurol Sci 1999 26:S2 S6.
57. Thomaides T, Tagaris G, Karageorgiou C. EEG and topographic frequency analysis in migraine attack before and after sumatriptan infusion. Headache 1996 36:111 4.
58. van der Post J, Schram MT, Schoemaker RC, Pieters MSM, Fuseau E, Pereira A et al. CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia 2002 22:271 81.
59. Shields KG, Goadsby PJ. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? Neurobiol Dis 2006 23:491 501.
60. Pascual J, del Arco C, Romon T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996 16:317 22.
61. Dobson CF, Tohyama Y, Diksic M, Hamel E. Effects of acute and chronic administration of antimigraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004 24:2 11.
62. Roberts C, Belenguer A, Middlemiss DN, Routledge C. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions. Eur J Pharmacol 1998 346:175 80.
63. Stamford JA, Davidson C, McLaughlin DP, Hopwood SE. Control of dorsal raphe 5-HT function by multiple 5-HT1 autoreceptors: parallel purposes or pointless plurality? Trends Neurosci 2000 23:459 65.
64. Levy D, Jakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci USA 2004 101:4274 9.
65. Bartsch T, Knight YE, Goadsby PJ. Activation of 5-HT (1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 2004 56:371 81.